Showing results (71-80 of 184) with videos related to
Sort By:
Pageof 19
Chemical Reviews|May 4, 2022
Continuum Modeling of Porous Electrodes for Electrochemical SynthesisJustin C Bui, Eric W Lees, Lalit M Pant, et al.Canadian Medical Association Journal|April 1, 1984
Bilateral breast cancer in northern Alberta: risk factors and survival patternsP E Burns, K Dabbs, C May, et al.Journal of Chronic Diseases|January 1, 1983
Interactions between benign breast disease and other risk factors for breast cancerJ H Lubin, L A Brinton, W J Blot, et al.International Journal of Cancer|December 1, 1981
Dietary factors and breast cancer riskJ H Lubin, P E Burns, W J Blot, et al.The American Journal of Gastroenterology|July 30, 2025
Inflammatory Bowel Disease and Risk of More than 1,500 Comorbidities: A Disease-wide Prediagnostic and Postdiagnostic Phenomic Association StudyAnthony C Ebert, Bram Verstockt, Martin Bøgsted, et al.Advances in Therapy|July 31, 2023
Modeling of Treatment Outcomes with Tofacitinib Maintenance Therapy in Patients with Ulcerative Colitis: A Post Hoc Analysis of Data from the OCTAVE Clinical ProgramMichael Chiorean, Marco Daperno, Charlie W Lees, et al.Journal of the National Cancer Institute|February 1, 1982
Risk factors for breast cancer in women in northern Alberta, Canada, as related to age at diagnosisJ H Lubin, P E Burns, W J Blot, et al.Alimentary Pharmacology & Therapeutics|October 15, 2013
A trial of mercaptopurine is a safe strategy in patients with inflammatory bowel disease intolerant to azathioprine: an observational study, systematic review and meta-analysisN A Kennedy, E Rhatigan, I D R Arnott, et al.Therapeutic Advances in Gastroenterology|January 6, 2022
Real-world experience with tofacitinib in ulcerative colitis: a systematic review and meta-analysisLaura A Lucaciu, Nathan Constantine-Cooke, Nikolas Plevris, et al.Annals of Surgery|November 1, 1989
Natural history of in situ breast cancer in a defined populationW J Temple, M Jenkins, F Alexander, et al.Pageof 19